Archon Biosciences
PrivateLast Round
Seed
Oct 30, 2024
Total Funding Raised
$27M
Company Overview
Archon Biosciences is a biotechnology company that develops computationally designed Antibody Cages (AbCs) to unlock therapeutic targets.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Application
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Archon Biosciences Comparables
Compare Archon Biosciences with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Accipiter Biosciences | 85% | |
| AI Proteins | 77% | |
| BigHat Biosciences | 76% |
Archon Biosciences Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Seed | Oct 30, 2024 |
Key People
Founding team and executive leadership
Archon Biosciences Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Duke University Management Company | Seed |
| Cornucopian Capital | Seed |
| United States Department of Defense | Grant |
| NIH RADx | Grant |
| WRF Capital | Seed |
| Pack Ventures | Seed |
| Washington Research Foundation Capital | Seed, Grant |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jul 1, 2024
Developing unique protein structures called Antibody Cages (AbCs).
Archon Biosciences Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request accessFrequently Asked Questions
Common questions about Archon Biosciences's valuation, stock price, and market status.
Is Archon Biosciences a public or private company?
Archon Biosciences is a private company.
What is the current stock price of Archon Biosciences?
Archon Biosciences is a private company with no public stock price. No recent secondary market data is available.
How much is Archon Biosciences worth (valuation)?
Valuation information for Archon Biosciences is not publicly available.
Can I buy Archon Biosciences stock?
Archon Biosciences shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.
When was Archon Biosciences's last funding round?
Archon Biosciences's most recent funding round was Seed on October 30, 2024.
Who are the main investors in Archon Biosciences?
Key investors in Archon Biosciences include Madrona Venture Group.
Will Archon Biosciences IPO soon?
No public IPO plans have been announced for Archon Biosciences.
How can I track Archon Biosciences secondary market activity?
Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Archon Biosciences's secondary market activity and sign up for updates.